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Abstract
Background: Microcirculation plays a vital role in the development of multiple organ failure in severe sepsis. The
effects of red blood cell (RBC) transfusions on these tissue oxygenation and microcirculation variables in early
severe sepsis are not well defined.
Methods: This is a prospective, observational study of patients with severe sepsis requiring RBC transfusions of one
to two units of non-leukoreduced RBCs for a hemoglobin < 7.0, or for a hemoglobin between 7.0 and 9.0 with
lactic acidosis or central venous oxygen saturation < 70%. This study took place in a 54-bed, medical-surgical
intensive care unit of a university-affiliated hospital. Thenar tissue oxygen saturation was measured by using a
tissue spectrometer on 21 patients, and a vaso-occlusive test was performed before and 1 hour after transfusion.
The sublingual microcirculation was assessed with a Sidestream Dark Field device concomitantly on 11 of them.
Results: RBC transfusion resulted in increase in hemoglobin (7.23 (± 0.87) to 8.75 (± 1.06) g/dl; p < 0.001). RBC
transfusion did not globally affect near-infrared spectrometry (NIRS)-derived variables. However, percent change in
muscle oxygen consumption was negatively correlated with baseline (r = - 0.679, p = 0.001). There was no
statistically significant correlation between percent change in vascular reactivity and baseline (p = 0.275). There was
a positive correlation between percent change in oxygen consumption and percent change in vascular reactivity (r
= 0.442, p = 0.045). In the 11 patients, RBC transfusion did not globally affect NIRS-derived variables or SDF-derived
variables. There was no statistically significant correlation between percent change in small vessel perfusion and
baseline perfusion (r = -0.474, p = 0.141), between percent change in small vessel flow and baseline flow (r =
-0.418, p = 0.201), or between percent change in small vessel perfusion and percent change in small vessel flow (r
= 0.435, p = 0.182).
Conclusions: In a small sample population, muscle tissue oxygen consumption, microvascular reactivity and
sublingual microcirculation were globally unaltered by RBC transfusion in severe septic patients. However, muscle
oxygen consumption improved in patients with low baseline and deteriorated in patients with preserved baseline.
Future research with larger samples is needed to further examine the association between RBC transfusion and
outcomes of patients resuscitated early in severe sepsis, with an emphasis on elucidating the potential contribution
of microvascular factors.
Introduction
In the United States, approximately 750,000 cases of
sepsis occur each year, of which at least 225,000 are
fatal. One study that evaluated the epidemiology of sep-
sis between 1979 and 2000 demonstrated an 8.7%
increase in the annual incidence of sepsis. The cost of
management of one septic patient has been estimated at
$50,000, amounting to annual costs of approximately
$17 billion. Sepsis is the second-leading cause of death
in noncoronary intensive care units (ICUs) and the
tenth leading cause of death overall. Organ failure
occurs in approximately one third of patients with sepsis
and severe sepsis is associated with an estimated mortal-
ity rate of 30-50%. Seventy percent of patients with
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or septic shock) die [1-8].
Red blood cell transfusion is one of the most com-
monly used interventions in the ICU to treat severe ane-
mia, which often occurs in sepsis. In the United States,
more than 14 million units of packed red blood cells
(RBCs) are administered annually, many of which are
administered in the ICU [9]. Approximately 40-80% of
RBC transfusions in the ICU are not given for bleeding,
but rather for low hemoglobin levels, for a decrease in
physiological reserve, or for alterations in tissue perfu-
sion [10,11]. In addition, RBC transfusion is recom-
mended as part of early goal-directed therapy for
patients with severe sepsis [12].
Patients with sepsis develop alterations in microvascu-
lar circulation, tissue oxygenation, and oxygen metabo-
lism, all of which play a major role in the development
of organ failure. Orthogonal polarization spectral (OPS)
and sidestream dark field (SDF) imaging devices both
provide high-contrast images of underlying microvascu-
lature [13]. Using these devices, investigators have
reported that the microcirculation is markedly altered in
sepsis, alterations are more severe in nonsurvivors, and
persistent microvascular alterations are associated with
development of multiple organ failure and death
[14-17]. The sublingual microcirculation has been the
most extensively studied in patients with critical illness
and sepsis.
Another noninvasive technique used is near-infrared
spectrometry (NIRS) [18,19], which measures skeletal
muscle tissue hemoglobin concentration and oxygen
saturation before and after stagnant ischemia. Tissue
ischemia is normally followed by arteriolar dilation and
a temporary rise in local blood flow, a phenomenon
termed reactive hyperemia (RH). RH is impaired in
patients with severe sepsis [20,21]. Using NIRS, investi-
gators have shown that oxygen consumption (during
stagnant ischemia) and microvascular reactivity (RH) are
altered in sepsis, are more severe in nonsurvivors, and
persistence is associated with development of multiple
organ failure and death [22-25].
The primary objective of this study was to evaluate the
effect of RBC transfusion in severe septic patients on
sublingual microvascular perfusion and flow using SDF
and on muscle tissue oxygenation, oxygen consumption,
and microvascular reactivity using NIRS. A secondary
objective was to correlate the variables obtained from
NIRS with those obtained from SDF.
Methods
Subjects
This prospective, observational study included 21 severe
septic patients according to standard definition [26]. All
patients received RBC transfusion for a hemoglobin <
7.0, or for a hemoglobin between 7.0 and 9.0 with lactic
acidosis, or central venous oxygen saturation < 70%. All
patients were clinically euvolemic (by CVP and/or echo-
cardiogram) and in the first 12 hours of sepsis. Exclu-
sion criteria included RBC transfusion in the preceding
72 hours, peripheral vascular disease, liver cirrhosis, age
< 18 years, active bleeding, shock secondary to any
other cause (cardiogenic, hemorrhagic, obstructive), and
pregnancy. Hemodynamic, NIRS-derived, and SDF-
derived variables were obtained immediately before
(baseline) and 1 hour after transfusion of 1 unit of
packed RBCs. During the study period, no bedside pro-
cedures were performed, doses of vasopressor and seda-
tive agents were kept constant, and the patient’s
position in bed (head of bed at 30 degrees elevation)
was not changed. This study was approved by the Insti-
tutional Review Board at St. John’s Mercy Medical Cen-
ter with waiver of written informed consent (# 09-953).
Red blood cell transfusion characteristics
Packed red blood cell units were obtained from the
blood bank (St. John’s Mercy Medical Center). None of
the RBC units transfused in this study were leukore-
duced. Storage solution (saline-adenine-glucose-manni-
tol) was added to RBCs before storage. The storage
period of RBCs is allowed up to 42 days.
Measurements
The temperature, heart rate, arterial pressure, central
venous pressure (when available), hemoglobin, central
venous oxygen saturation, lactic acid, and arterial blood
gases were recorded before and 1 hour after transfusion.
The Acute Physiology and Chronic Health Evaluation II
(APACHE II) score [27] was obtained at admission to the
ICU, and the Sequential Organ Failure Assessment score
[28] was obtained on the study day. The length of RBC
storage before transfusion was noted in each case. NIRS
measurements were obtained on all patients. SDF mea-
surements were obtained for 11 patients. SDF measure-
ments could not be obtained for all patients due to
technical difficulties or safety concerns (i.e., some patients
were not intubated, some were not sedated sufficiently).
NIRS measurements and analysis
The thenar tissue oxygen saturation (StO2)a n dt h et i s -
sue hemoglobin index (THI), an indicator of the blood
volume in the region of the microvasculature sensed by
the NIRS probe [29], were measured using a tissue spec-
trometer (InSpectra™ Model 650; Hutchinson Technol-
ogy Inc., Hutchinson, MN, USA). This device uses
reflectance mode probes to measure scattered light
reflected at some distance from where the light is trans-
mitted into the thenar muscle. Sample measurement sig-
nals were updated every 2 seconds.
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arterial pressure > 65 mmHg and no change in vaso-
pressor doses for 2 hours), the NIRS probe was placed
on the skin of the thenar eminence and a sphygmoman-
ometer cuff was placed around the arm over the bra-
chial artery. A large bore tube/cuff that inflates and
deflates in less than one second was used to avoid cuff
inflation and deflation from affecting the slope measure-
ments. After a 3-minute period necessary to stabilize the
StO2 signal, arterial inflow was stopped by inflation of
the cuff to 50 mmHg above the systolic arterial pressure.
After 3 minutes of ischemia the cuff pressure was
released, and StO2 was continuously recorded for
another 3 minutes (reperfusion period). Continuous
measurements of the StO2 and THI were obtained during
the vaso-occlusive test. Baseline StO2 and THI were
recorded before the ischemic period and THI was
recorded after 1 minute of occlusion. During occlusion,
we calculated the StO2 desaturation slope (%/minute)
o b t a i n e df r o mt h er e g r e s s i o nl i n eo ft h ef i r s tm i n u t eo f
StO2 decay after occlusion [29]. This is a representation
of oxygen consumption. During the reperfusion phase,
the StO2 upslope (%/second) was obtained from the
regression line of the first 14 seconds of increased StO2
(seven StO2 values) following the ischemic period. This
StO2 upslope of the reperfusion phase was used to
quantify the intensity of the reactive hyperemic response
following release of the occluding cuff. The percent
change in recovery (upslope) was calculated as the dif-
ference between the StO2 upslopes of the reperfusion
phase after and before transfusion divided by the StO2
upslope before transfusion. Muscle oxygen consumption
(NIRVO2) was calculated as the product of the inverse
value of the StO2 desaturation slope and the mean THI
over the first minute of arterial occlusion [29] and is
expressed in arbitrary units:
NIRVO2 = (StO2desaturation slope − 1) × (THIstartcuff + THI1 min)]/2
Percent change in NIRVO2 (downslope) was calcu-
lated as the difference between the NIRVO2 values after
and before transfusion divided by NIRVO2 values before
transfusion.
SDF measurements and analysis
Sidestream dark field imaging was performed by using
a handheld device that illuminates an area of interest.
Light is emitted by a circle of light-emitting diodes.
The reflected light is returned through the inner
image-conducting core, which is optically isolated from
the light-emitting diodes and caught on camera.
Although assessing the microcirculation is based on
light absorption by the hemoglobin contained in RBCs,
this technique remains valid in anemia, as well as
during acute changes in hemoglobin concentration
[30]. Sidestream dark field imaging and semiquantita-
tive analysis were performed as described in detail
elsewhere [31]. In short, video images (Microscan;
Microvision Medical, Amsterdam, the Netherlands)
were captured via connection to a laptop computer.
After the removal of saliva and other secretions using
gauze, the device was gently applied (without signifi-
cant pressure) to the lateral side of the tongue, in an
area approximately 1.5-4 cm from the tip of the ton-
gue. Three video recordings of 20 seconds in duration
each at two time points (i.e., baseline and 1 hour post-
transfusion) were analyzed by dividing the image into
four equal quadrants. Quantification of flow (microvas-
cular flow index-MFI) was scored per quadrant, for
each size group of microvessel diameter: small (10-25
microns), medium (25-50 microns), and large (50-100
microns). Quantification of flow (0 = no flow, 1 =
intermittent flow, 2 = sluggish flow, and 3 = continu-
ous flow) was recorded. Microvascular flow index was
calculated as the sum of each quadrant score divided
by the number of quadrants in which the vessel type
was visible. The final MFI was averaged over a maxi-
mum of 12 quadrants (three regions, four quadrants
per region) derived from the overall flow impressions
of all vessels with a particular range of diameter in a
given quadrant. The heterogeneity index was calcu-
lated, following the method of Trzeciak and colleagues
[16], as the difference between the highest and lowest
MFI, divided by the mean MFI of all sublingual sites at
as i n g l et i m ep o i n t .C a l c u l a t i o no ft o t a l( s m a l l )v e s s e l
density was performed with the AVA 3.0 software
package (MicroVision Medical, Amsterdam, The Neth-
erlands), as described and validated recently [32] using
a cutoff diameter for small vessels < 20 microns. After
stabilization of the images using the AVA 3.0 software,
we defined the perfused (small) vessel density (PVD)
and the proportion of perfused (small) vessels (PPVs)
in terms of the number and percentage of crossings
with perfused (small) vessels per total length of three
equidistant horizontal and three equidistant vertical
lines (De Backer score), or as total length of perfused
vessels divided by total surface of area (mm/mm
2). To
reduce observer measurement bias, sidestream dark-
field images were analyzed off-line and in a blinded
fashion by one of the investigators (FS), who was
blinded to the patient’s clinical course and the order of
the sequences.
Percent change in PPV was calculated as the differ-
ence between the PPV values after and before transfu-
sion divided by PPV values before transfusion. Percent
change in MFI was calculated as the difference between
the MFI values after and before transfusion divided by
MFI values before transfusion.
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Descriptive statistics were performed for the full and
subgroup samples to assess similarities in patient char-
acteristics, including age, gender, source of infection(s),
age of blood, APACHE II score, and discharge status (i.
e., mortality). Changes in hemodynamic and other
observed measurements taken before (pre) and 1 hour
after (post) the transfusion were assessed by a paired t
test. Mean, standard deviation and p value were
reported for each comparison. Analysis for the full sam-
ple and subgroup were conducted separately. A Pearson
correlation coefficient (PCC) was calculated to describe
the association between percent change in NIRVO2
(downslope), baseline NIRVO2 (downslope), percent
change in recovery (upslope), and baseline upslope
using subjects in the full sample. This method was
repeated for the subgroup with additional comparisons,
including percent change in PPV for small vessels vs.
baseline PPV, percent change in MFI, percent change in
NIRVO2 (downslope), and percent change in recovery
(upslope). Percent change in MFI for small vessels was
correlated with baseline MFI, percent change in
NIRVO2 (downslope) and percent change in recovery
(upslope). All analyses were conducted with SPSS/
PASW version 18 (Chicago, IL) by an investigator (EA)
who was not involved with data collection or analysis of
sidestream darkfield images.
Results
The study included 21 severe septic patients with NIRS-
derived data (full sample), 11 of whom also had SDF-
derived data (subgroup sample; Table 1). The median
APACHE II scores were 24 and 25 for the full sample
and the subgroup sample respectively, and in-hospital
mortality was 47.6% and 45.6%, respectively. No transfu-
sion-related adverse reactions were observed during the
study. The mean arterial pressure increased from 69.67
mmHg (± 8.76 mmHG) to 73.52 mmHg (± 11.08
mmHg; p = 0.08) in the full sample, and from 67.36
mmHg (± 7.97 mmHG) to 73.18 mmHg (± 12.16
mmHg; p = 0.02) in the subgroup sample (Table 2). The
median RBC storage time was 32 days (21-39) in the
full sample and 32 days (22-39) in the subgroup sample.
Full sample
In the full sample, blood transfusion resulted in increase
in hemoglobin (7.23 g/dl (± 0.87 g/dl) to 8.75 g/dl (±
1.06 g/dl; p < 0.001; Table 2). Red blood cell transfusion
did not globally affect NIRS-derived variables (Table 2;
Figure 1A,B). However, percent change in NIRVO2 was
negatively correlated with baseline NIRVO2 (r = -0.679,
p = 0.001; Figure 2A). There was no statistically signifi-
cant correlation between percent change in recovery
(upslope) and baseline recovery upslope (p = 0.275;
Figure 2B). There was a positive correlation between
percent change in NIRVO2 and percent change in the
recovery upslope (r = 0.442, p = 0.045; Figure 3A).
Subgroup sample
In the subgroup sample, blood transfusion resulted in
increase in hemoglobin (7.48 g/dl (± 0.83 g/dl) to 8.95 g/
dl (± 1.12 g/dl); p < 0.001; Table 2). Red blood cell trans-
fusion did not globally affect NIRS-derived variables or
SDF-derived variables (Tables 2 and 3; Figure 1C,D).
Similar to the full sample, percent change in NIRVO2
was negatively correlated with baseline NIRVO2 (r =
-0.689, p = 0.019; Figure 2A). There was no statistically
significant correlation between percent change in the
recovery upslope and baseline recovery upslope (p =
0.407; Figure 2B). There was a positive correlation
between percent change in NIRVO2 and percent change
in the recovery upslope (r = 0.775, p = 0.005; Figure 3A).
These findings suggest that the subgroup sample is simi-
lar in most observable regards to the full sample.
THI results
THI variables behaved exactly similar to StO2 variables
(data not shown). THI correlated with StO2.F o re x a m -
ple, in the full sample before transfusion, THI positively
Table 1 Characteristics of the study groups
Full sample
a
(n = 21)
Subgroup
b
(n = 11)
Age (yr) 71 (41-87) 73 (55-83)
Male gender, % 11 (52.4) 5 (45.5)
APACHE II score 24 (17-39) 25 (20-39)
SOFA score 8 (3-17) 9 (3-16)
Source of infection, %
Lung 11 (52.4) 3 (27.3)
Abdomen 6 (28.6) 4 (36.4)
Urinary tract 3 (14.3) 3 (27.3)
Line 1 (4.7) 1 (9.0)
Vasopressors/inotropes dose
c
Norepinephrine, mcg/min 10; 10 (2-40) 6; 10 (2-25)
Dobutamine, mcg/kg/min 4; 5 (2.5-10) 2; 3.7 (2.5-5)
Sedation/analgesic dose
c
Midazolam, mg/hr 7; 2 (2-4) 4; 2 (2-4)
Fentanyl, mcg/hr 8; 100 (50-400) 4; 100 (50-400)
Human recombinant activated protein
C, %
14.3 27.3
Renal replacement therapy, % 33.3 27.3
Red blood cell storage time (days) 32 (21-39) 32 (22-39)
In-hospital mortality, % 47.6 45.6
Data are presented as median (25th to 75th percentiles) or n (%).
APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential
Organ Failure Assessment.
aFull sample, all with NIRS data.
bSubgroup, all have both NIRS and SDF data.
cn; dose.
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Page 4 of 11Table 2 Physiologic and near-infrared spectroscopy-derived variables before and 1 hour after red blood cell
transfusion
Full Sample Subgroup
Baseline After
Transfusion
Baseline After
Transfusion
n Mean (SD) Mean
(SD)
p n Mean (SD) Mean
(SD)
p
Hemoglobin (g/dl) 21 7.2 (0.8) 8.7 (1.1) 0.00 11 7.5 (0.8) 8.9 (1.1) 0.00
Heart Rate (beats/min) 21 91
(15)
91 (15) 0.34 11 91 (18) 89 (18) 0.14
Temperature (°F) 21 97.8 (1.2) 97.7 (1.2) 0.65 11 98.1 (1.2) 98.1 (1.2) 0.96
Mean arterial pressure (mmHg) 21 69.6 (8.7) 73.5 (11.1) 0.08 11 67.3 (7.9) 73.2 (12.1) 0.02
Central venous pressure (mmHg) 12 16 (5.7) 16.2 (4.3) 0.79 7 15.2 (4.3) 16.1 (5) 0.34
Lactate (mmol/l) 12 4.1 (3.5) 3.9 (3.4) 0.47 6 3.7 (2.1) 3.8 (2.4) 0.73
Arterial partial pressure of oxygen (mmHg) 6 124.6 (97.6) 95.2 (29.2) 0.49 3 164 (137.1) 101 (38) 0.5
pH 6 7.3(0.1) 7.3 (0.1) 0.62 3 7.3(0.1) 7.3(0.1) 0.24
Central venous oxygen saturation (%) 10 59.1 (9.2) 63.8 (8.8) 0.11 6 62.3 (9.2) 64.6 (8.9) 0.48
SaO2/FiO2 21 264.1
(114.8)
270.9
(97.2)
0.46 11 249.5
(105.9)
259.1
(91.5)
0.19
Thenar tissue oxygen saturation (%) 21 76.2 (9.3) 75.8 (8.1) 0.80 11 76.8 (8.4) 75.8 (8.8) 0.69
Tissue hemoglobin index (arbitrary units) 21 10.7 (3.4) 12.2 (3.5) 0.01 11 10.9 (3.1) 12.2 (4.1) 0.07
Thenar tissue oxygen saturation upslope of the reperfusion phase
(%/second)
21 2.5 (1.3) 2.6 (1.5) 0.39 11 2.2 (1) 2.1 (1.1) 0.78
Muscle oxygen consumption (arbitrary units) 21 113.6
(56.43)
124.1
(43.6)
0.26 11 104.4 (41.1) 112.5
(40.3)
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Figure 1 Tissue oxygenation and microcirculation variables for individual patients from before and after transfusion. A Recovery slopes
for individual patients from before and after transfusion for full sample. B NIRVO2 for individual patients from before and after transfusion for
full sample. C PPV small vessels for individual patients from before and after transfusion for subgroup sample. D MFI small vessels for individual
patients from before and after transfusion for subgroup sample.
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Page 5 of 11correlated with StO2 (r = 0.47, p = 0.03). THI increased
after transfusion in the full sample (Table 2), but not in
the subgroup sample. There was no correlation between
THI and hemoglobin levels before transfusion (r = 0.11,
p = 0.64) or after transfusion (r = 0.16, p = 0.49).
Correlations between variables from NIRS and SDF
There was no statistically significant correlation between
percent change in small vessel PPV and baseline small
vessel PPV (r = -0.474, p = 0.141; Figure 2C). There was
no statistically significant correlation between percent
change in small vessel MFI and baseline small vessel
MFI (r = -0.418, p = 0.201; Figure 2D). There was no
statistically significant correlation between percent
change in small vessel PPV and percent change in small
vessel MFI (r = 0.435, p =0 . 1 8 2 ;F i g u r e3 B ) .A l t h o u g h
there was no significant correlation between NIRS-
derived variables (NIRVO2, recovery upslope) and SDF-
derived variables (PPV, MFI), all changes in NIRS-
derived variables occurred in the same direction as SDF-
derived variables (Figures 2 and 3).
Discussion
The main finding of our study was that RBC transfusion
had no global effect on muscle oxygen saturation, oxy-
gen consumption, microvascular reactivity, vessel perfu-
sion, or microvascular flow in severe septic patients.
However, there was considerable variance between sub-
jects. There was an improvement in oxygen consump-
tion in patients with altered oxygen consumption at
baseline and deterioration in oxygen consumption in
patients with preserved baseline oxygen consumption.
Prospective studies in ICU patients showed a higher
mortality rate in patients receiving RBCs than in those
not receiving RBCs. These results suggest that a more
restrictive transfusion strategy was safe in the ICU
A B
C D
Figure 2 Tissue oxygenation and microcirculation variables: relationship between baseline and percent change from before and after
transfusion. A Tissue oxygen consumption (NIRVO2) significantly correlates positively with microvascular reactivity (recovery - upslope) in both
the full sample (r = 0.442, p = 0.045) and in the subgroup sample (r = 0.775, p = 0.005). B Relationship between baseline recovery (upslope)
and percent change in recovery (upslope) for both the full sample (r = -0.25, p = 0.275) and subgroup sample (r = -0.278, p = 0.407). C
Relationship between baseline small vessel perfusion (PPVsmall vessel) and percent change in small vessel perfusion for the subgroup sample (r
= -0.474, p = 0.141). D Relationship between baseline small vessel flow (MFI small vessel) and percent change in small vessel flow in the
subgroup sample (r = -0.418, p = 0.201).
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[33,34]. Guidelines published as part of the Surviving
Sepsis Campaign [12] have endorsed use of RBCs in the
treatment of patients with severe sepsis who show evi-
dence of hypoperfusion. This recommendation is pri-
marily based on data published by Rivers et al. [35] who
evaluated a bundle approach to patients in severe sepsis.
Red blood cell transfusion to obtain a hematocrit of 30%
is included in this bundle for patients with a central
venous oxygen saturation < 70%. Patients achieving this
goal had better outcomes than patients who did not
reach the goal. The specific effect of transfusion was not
evaluated in this study; however, because the investiga-
tion was designed to assess the overall bundle rather
than its component parts. Using NIRS or SDF, several
investigators have reported that microcirculation is
markedly altered in sepsis, that these alterations are
more severe in nonsurvivors than in survivors, that per-
sistent microvascular alterations are associated with
development of multiple organ failure and death, and
that microvascular alterations are the most sensitive and
specific predictor of outcome in septic patients
[14-17,22-25]. Our goal was to study the effect of RBC
transfusion on microvascular variables in severe septic
patients using both NIRS and SDF.
The effects of RBC transfusion on the microcircula-
tion in sepsis could be numerous. Several studies have
demonstrated that RBC rheology is impaired (increased
A B
Figure 3 Correlations among Tissue oxygenation variables and Microcirculation variables. A Tissue oxygen consumption (NIRVO2)
significantly correlates positively with microvascular reactivity (recovery - upslope) in both the full sample (r = 0.442, p = 0.045) and in the
subgroup sample (r = 0.775, p = 0.005). B Small vessel Microvascular Flow Index (MFIsmall–marker of flow) correlates positively with proportion
of perfused small vessels (PPVsmall–marker of perfusion) in the subgroup sample (not statistically significant; r = 0.435, p = 0.182).
Table 3 Sidestream Dark Field-derived microcirculatory variables before and 1 hr after red blood cell transfusion
Subgroup Baseline After transfusion
Measurement Vessel size n Mean (SD) Mean (SD) p
Total vessel density (mm/mm
2) Small 11 22.4 (5.9) 21.5 (5.5) 0.36
Total vessel density (mm/mm
2) Large 11 3.4 (1.3) 3.9 (1) 0.2
Total vessel density (mm/mm
2) All 11 25.7 (6.4) 25.4 (6) 0.73
Perfused vessel density (mm/mm
2) Small 11 9.5 (4.8) 9.4 (4.8) 0.91
Perfused vessel density (mm/mm
2) Large 11 3 (1.5) 3.7 (1.2) 0.09
Perfused vessel density (mm/mm
2) All 11 12.5 (5.4) 13.3 (4.7) 0.53
Proportion of perfused vessels (%) Small 11 37.6 (21.5) 38.2 (21.8) 0.85
Proportion of perfused vessels (%) Large 11 100 100 1
Proportion of perfused vessels (%) All 11 51.6 (23.8) 53.9 (20.9) 0.45
De Backer score (n/mm) 11 14.7 (3.8) 14.8 (3.5) 0.91
Microvascular Flow Index Small 11 1.6 (0.7) 1.6 (0.7) 0.76
Microvascular flow index All 11 2.3 (0.4) 2.4 (0.3) 0.3
Heterogeneity index (%) 11 0.3 (0.2) 0.4 (0.3) 0.19
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shape) in sepsis [36-39]. These alterations could contri-
bute to the microcirculatory alterations observed in cri-
tically ill patients [39]. RBC also can act as oxygen
sensor, which can modulate tissue oxygen flow variables
-b yt h er e l e a s eo ft h ev a s o d i l a t o r s ,n i t r i co x i d e[ 4 0 , 4 1 ] ,
or ATP [42]. This release of vasodilators from RBCs
during hypoxia could be impaired during storage and/or
sepsis. Storage of RBCs decreases levels of 2,3-dipho-
sphoglycerate and adenosine triphosphate (ATP) levels
with a resultant increase in oxygen affinity and a
decrease in the ability of hemoglobin to offload oxygen.
Morphological changes in erythrocytes occur during sto-
rage which may result in increased fragility, decreased
viability, and decreased deformability of red blood cells.
A release of a number of substances occurs during sto-
rage resulting in such adverse systemic responses as
fever, cellular injury, alterations in regional and global
blood flow, and organ dysfunction. Several studies have
demonstrated that transfusion with RBCs that have been
stored for long time periods is associated with poorer
oxygen delivery than is transfusion with fresher cells
[43-49]. The median RBC storage time in our study was
32 days, which is similar to other studies. A recent lit-
erature review reported no strong association between
duration of storage and complications [50]. In addition,
Creteur et al. [51] using NIRS and Sakr et al. [52] using
OPS showed that RBC storage time had no influence on
the microvascular response to red blood cell transfusion.
Our study differs from Creteur et al. in several points.
We studied severe septic patients, whereas Creteur et al.
studied hemodynamically stable patients, 41% of whom
had sepsis. We transfused older (median RBC storage
time = 32 vs. 18 days) RBCs; ours were all nonleukore-
duced, whereas theirs were all leukoreduced. We used
both NIRS and SDF in our study, whereas they only
used NIRS. Our study also differed from Sakr et al. We
transfused older blood (median RBC storage time = 32
vs. 24 days); ours were all nonleukoreduced, whereas
theirs were all leukoreduced. We used both NIRS and
SDF in our study, whereas they only used OPS (older
version of SDF). In a very recent review on monitoring
the microcirculation in critically ill patients, De Backer
et al. concluded that a monitoring device should be able
to detect capillary perfusion, flow, and heterogeneity of
perfusion. This is best achieved with handheld microvi-
deoscopic techniques, such as OPS and SDF. They also
concluded that the use of vascular occlusion tests with
laser Doppler or NIRS investigates microvascular reac-
tivity, another important, but different, aspect of micro-
vascular function. De Backer suggested that “Combining
techniques may be of interest in the future” [53]. To our
knowledge, our study is the only human study that
employed both techniques in monitoring the impact of
an intervention on the microcirculation. Each of these
three studies showed similar findings. Creteur et al.
demonstrated an improvement in microvascular reactiv-
ity and tissue oxygen consumption in patients with
altered microvascular reactivity and tissue oxygen con-
sumption at baseline and deterioration in microvascular
reactivity and tissue oxygen consumption in patients
with preserved baselines [51]. Sakr et al. showed an
improvement in sublingual microvascular perfusion in
patients with altered perfusion at baseline and deteriora-
tion in sublingual microvascular perfusion in patients
with preserved baseline perfusion [52]. All showed no
global effect of RBC transfusion on the microvascular
variables.
In a recent study that evaluated perioperative RBC
transfusions in patients who underwent cardiac surgery
using SDF and sublingual reflectance spectrophotome-
try, Yuruk et al. showed that RBC transfusion improved
sublingual microcirculatory density, but not perfusion
velocity, and improved microcirculatory oxygen satura-
tion [54]. Their study included a totally different patient
population, patients with (relatively) healthy
microcirculation.
Why do some patients show beneficial effects of RBC
transfusions while others do not? Friedlander et al.
observed that RBC transfusions improved RBC deform-
ability in patients with sepsis, probably by replacing
rigid, endogenous RBCs by less dysfunctional, exogenous
RBCs [55]. Transfusions may therefore be deleterious
when performed in patients with preserved deformabil-
ity, vasoreactivity, perfusion, and/or flow but may be
favorable when performed in patients in whom these
variables are markedly altered.
Interestingly, RBC transfusion-induced changes in
NIRVO2, in the recovery upslope of the reperfusion
phase, in PPV, and in MFI were all in the same direc-
tion, suggesting that an improvement or worsening in
microvascular reactivity, microvascular perfusion, and
microvascular blood flow m a yb ea s s o c i a t e dw i t ha n
increase or decrease in local muscle oxygen consump-
tion, respectively.
NIRS-derived variables showed changes in the same
direction compared with SDF-derived variables (Figures
2 and 3). These changes were not, however, statistically
significant. This is likely secondary to a small sample
size. In fact that these two devices monitor different
aspects of the microvasculature, as well as different
organs also may have contributed. Hence, using both
devices may be complimentary and a point of strength
for this study.
Our study has its limitations. Our small sample size
and the fact that some variables could not be obtained
in some patients is an obvious limitation. The limited
number of patients does not make it possible to
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parameters could really influence the final response to
RBC transfusion. NIRS monitors hemoglobin oxygen
saturation in arterioles, venules, and capillaries in the
measured volume of tissue, and the relative contribu-
tions of arterial, venous, and capillary blood within the
measured volume of tissue cannot be determined. NIRS
does not measure microcirculatory blood flow or perfu-
sion. It also targets muscle tissue, specifically the thenar
muscle. SDF monitors the capillaries and venules (not
arterioles), but this device monitors the actual flow and
perfusion and their heterogeneity in the microvessels.
SDF data could be analyzed only semiquantitatively.
SDF targets the sublingual mucosa, which shares a simi-
lar embryonic origin with the digestive mucosa (always
involved pathologically in sepsis) but may not reflect
other microcirculatory beds. Our measurements were
restricted to 1 hr after RBC transfusion, therefore, later
alterations due to transfusion may have been missed.
However, longer follow-up periods are practically diffi-
cult because of inevitable changes in therapy and proce-
dures in these critically ill patients that could
themselves affect the microcirculation and other out-
comes. THI increased after transfusion in the full sam-
p l e( T a b l e2 ) ,w h i c hc o u l da l t e rt h eN I R V O 2
measurements (refer to NIRS measurements and analy-
sis above). THI does not reflect systemic hemoglobin
levels as a result of Fahraeus effect, heterogeneous flow
distributions, and local conditions (such as vasoconstric-
tion and edema) [56,57]. In addition, Doerschug et al.
showed that the THI was not related to blood hemoglo-
bin concentration in patients with severe sepsis [22].
Similarly, in our study, there was no correlation between
THI and hemoglobin levels before transfusion (r = 0.11,
p = 0.64) or after transfusion (r = 0.16, p = 0.49). More-
over, despite the increase in THI in the full sample,
there was an improvement in NIRVO2 in patients with
altered baseline and deterioration in NIRVO2 in patients
with preserved baseline in both the full sample and the
subgroup sample, suggesting that this relationship is
real. Because StO2 represents the average of the hemo-
globin oxygen saturation in arterioles, venules and capil-
laries in the whole tissue sample, NIRS is not able to
demonstrate changes on microvascular density or het-
erogeneity. As a result, we must continue to explore the
meaning of reactive hyperemia as a surrogate of micro-
vascular functionality.
Conclusions
The effects of RBC transfusions on microvascular oxyge-
nation, consumption, reactivity, perfusion, and flow are
quite variable and may be dependent on baseline values.
In this observational study of limited size, no effect of
RBC transfusion on any measured microcirculation
variables in severe septic patients was observed. This
study does suggest that better means of identifying the
need for transfusion are needed and that blindly trans-
fusing to an arbitrarily set (and high) Hb may be detri-
mental. This study involves a small sample of patients,
based on which strong recommendations cannot be
made. Future research with larger samples is needed to
further examine the association between RBC transfu-
sion and outcomes of patients resuscitated early in
severe sepsis, with an emphasis on elucidating the
potential contribution of microvascular factors.
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